LifeStance Health Group (NASDAQ:LFST) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of LifeStance Health Group (NASDAQ:LFST) from a buy rating to a strong-buy rating in a report released on Saturday morning.

Other research analysts have also issued research reports about the stock. KeyCorp raised their target price on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Zacks Research downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. Barclays increased their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. BTIG Research raised their price objective on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Finally, JPMorgan Chase & Co. lifted their target price on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $12.12.

LifeStance Health Group Stock Up 1.0%

Shares of LFST opened at $12.55 on Friday. The business’s fifty day moving average price is $10.49 and its two-hundred day moving average price is $8.26. The firm has a market capitalization of $4.87 billion, a price-to-earnings ratio of 96.55 and a beta of 1.14. LifeStance Health Group has a 52 week low of $4.77 and a 52 week high of $12.76. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. The company had revenue of $435.35 million during the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The firm’s quarterly revenue was up 26.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.01) earnings per share. On average, analysts predict that LifeStance Health Group will post 0.15 earnings per share for the current year.

Insider Buying and Selling

In other news, CTO Vukasin Paunovich sold 44,394 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $481,674.90. Following the completion of the transaction, the chief technology officer directly owned 247,446 shares in the company, valued at approximately $2,684,789.10. The trade was a 15.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the sale, the insider directly owned 98,101,407 shares of the company’s stock, valued at approximately $1,041,836,942.34. This trade represents a 12.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 14,629,850 shares of company stock valued at $154,952,012 over the last 90 days. 3.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On LifeStance Health Group

Hedge funds have recently bought and sold shares of the company. Larson Financial Group LLC grew its holdings in shares of LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after buying an additional 3,791 shares during the period. KBC Group NV bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at $29,000. EverSource Wealth Advisors LLC raised its stake in LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after buying an additional 5,404 shares during the period. Bayesian Capital Management LP bought a new position in LifeStance Health Group during the second quarter worth about $52,000. Finally, PNC Financial Services Group Inc. lifted its holdings in LifeStance Health Group by 615.3% during the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after acquiring an additional 7,987 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.